We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Propath Receives Queen’s Award for Enterprise

News   Apr 26, 2017 | Original story from Propath

 
Propath Receives Queen’s Award for Enterprise
 
 
 

RELATED ARTICLES

Sprouty 1 and Sprouty 2 Offer Potential to Combat Cancer

News

Two molecules, Sprouty 1 and Sprouty 2, modify the survival of effector T cells and the development of memory CD8 T cells. These findings offer promising potential for immunotherapeutic strategies to combat cancer and chronic infections.

READ MORE

Antibiotic Candidates Discovered

News

MIT researchers have discovered that peptides normally secreted by cells that line the stomach have previously unknown antimicrobial activity.

READ MORE

PCR Assay Helps ID Sarcoma Mutations

News

Sarcomas are rare tumors that are often misdiagnosed. A report in the Journal of Molecular Diagnostics describes a new assay, anchored multiplex PCR (AMP)-based targeted next-generation-sequencing (NGS), that is better able to identify genetic diagnostic markers of the cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE